Dengue IgG/IgM/NS1 Combo Test Device (WB/S/P)

The Dengue IgG/IgM/NS1 Combo Test Device combines three important dengue markers: Dengue NS1 antigen, Dengue IgM antibodies, and Dengue IgG antibodies. By detecting NS1 + IgM + IgG, the Dengue IgG/IgM/NS1 Combo Test Device helps support broader dengue screening than NS1-only or antibody-only rapid tests.

• Dengue infection can vary by timing during illness progression.
• A person tested very early may show NS1 positivity before antibody levels rise.
• A person tested later may show IgM or IgG positivity when NS1 antigen is reduced.
• The Dengue IgG/IgM/NS1 Combo Test Device supports wider screening coverage across different stages of infection.

The Dengue IgG/IgM/NS1 Combo Test Device by LARKSOIS Pharma may be used in professional diagnostic and healthcare screening environments.

Applications

• Early dengue antigen screening
• Later-stage antibody response detection
• Primary and secondary infection assessment support
• Public health surveillance
• Outbreak response
• Hospital and clinic screening workflows
• Testing in dengue-endemic regions
• Emergency department screening
• International infectious disease testing programs

• The Dengue IgG/IgM/NS1 Combo Test Device works on a rapid lateral flow immunochromatographic method.
• The specimen moves across the membrane by capillary action.
• If dengue NS1 antigen, IgM antibodies, or IgG antibodies are present, visible colored lines appear in the corresponding test regions.
• A control line confirms valid sample flow and proper test performance.

The Dengue IgG/IgM/NS1 Combo Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection of Dengue NS1 antigen and Dengue IgG/IgM antibodies from whole blood, serum, or plasma specimens.

Benefits

• Rapid qualitative detection of Dengue NS1 antigen
• Qualitative detection of Dengue IgM antibodies
• Qualitative detection of Dengue IgG antibodies
• Suitable for whole blood, serum, or plasma specimens
• Supports screening across different infection stages
• Simple visual result interpretation
• No major instrument required
• Suitable for international infectious disease testing programs

The Dengue IgG/IgM/NS1 Combo Test Device is designed for whole blood, serum, or plasma specimens. Correct specimen collection and handling are important for reliable test performance.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Add whole blood, serum, or plasma to the sample well
• Add buffer as instructed in the kit insert
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, handling, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Dengue IgG/IgM/NS1 Combo Test Device by LARKSOIS Pharma is designed to detect Dengue NS1 antigen together with Dengue IgG and IgM antibodies in whole blood, serum, or plasma specimens. This combination supports broader dengue screening across different stages of infection.

• NS1 antigen positivity may suggest early or acute dengue infection.
• IgM antibody positivity may suggest recent dengue infection or developing immune response.
• IgG antibody positivity may suggest past dengue exposure, later-stage infection, or secondary dengue infection.
• Healthcare professionals should interpret results with symptoms, exposure history, clinical findings, and additional laboratory evaluation.

The Dengue IgG/IgM/NS1 Combo Test Device is a screening aid and should not be the only basis for diagnosis. False positive or false negative results may occur due to timing, specimen quality, cross-reactivity, immune response variation, or incorrect procedure.

Instructions

• NS1 may decline after the early phase
• IgM may not appear immediately after fever onset
• IgG may remain positive from previous infection
• Cross-reactivity with related flaviviruses may occur
• Negative results do not always rule out dengue
• Incorrect procedure may affect results
• Clinical symptoms and physician evaluation remain important
• Confirmatory testing may be required when clinically indicated

Instructions

• Rapid qualitative detection of Dengue NS1 antigen
• Qualitative detection of Dengue IgM antibodies
• Qualitative detection of Dengue IgG antibodies
• Supports screening across different infection stages
• Suitable for whole blood, serum, or plasma specimens
• Simple visual result interpretation
• No major instrument required
• Useful for hospitals, clinics, and laboratories

Note

The Dengue IgG/IgM/NS1 Combo Test Device by LARKSOIS Pharma is developed for professional users who need fast and practical dengue screening support.

Steps

• Bring the test device and specimen to room temperature
• Open the sealed pouch and place the cassette on a clean surface
• Add whole blood, serum, or plasma to the sample well
• Add buffer as instructed in the kit insert
• Wait for the recommended reaction time
• Read NS1, IgM, IgG, and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety rules

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

NS1 positive may suggest early or acute dengue infection. IgM positive may suggest recent dengue infection or developing immune response. IgG positive may suggest past dengue exposure, later-stage infection, or secondary dengue infection.

Negative

All markers negative means no dengue NS1 antigen, IgM, or IgG was detected. If symptoms continue, repeat testing or additional testing may be required.

Invalid

If the control line does not appear, the test is invalid and should be repeated with a new device according to the product insert.

Instructions

• Store the Dengue IgG/IgM/NS1 Combo Test Device according to the label and package insert
• Store in a dry place
• Keep sealed until use
• Do not freeze
• Protect from sunlight
• Avoid moisture and heat
• Do not use expired kits
• Use immediately after opening

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens as potentially infectious
• Wear gloves during testing
• Do not reuse test cassettes
• Avoid sample cross-contamination
• Do not use damaged or expired devices
• Read results only within the correct time window
• Confirm results where clinically required

LARKSOIS Pharma provides international-quality rapid diagnostic solutions for hospitals, laboratories, clinics, importers, distributors, NGOs, and public health organizations. The Dengue IgG/IgM/NS1 Combo Test Device is designed for fast, simple, and practical dengue screening across global healthcare markets.

Advantages

• International diagnostic product focus
• Reliable rapid testing solutions
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product format
• Supports dengue screening workflows
• Practical WB/S/P testing format
• Quality-focused standards under LARKSOIS Pharma